Fecal B-cell-activating factor as a new noninvasive marker in the evaluation of ulcerative colitis Egyptian patients: a comparative cross-sectional study
Background and aim Diagnosis of ulcerative colitis (UC) is suspected clinically and confirmed through endoscopic biopsy. It can be followed-up and assessed by noninvasive biomarkers such as fecal calprotectin. Recently, B-cell-activating factor (BAFF) has been proposed to be a regulator of B-cell an...
Saved in:
Main Authors: | Hany A Hussein (Author), Rasha S Mohamed (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systematic Review with Meta-Analysis: Fecal Calprotectin as a Surrogate Marker for Predicting Relapse in Adults with Ulcerative Colitis
by: Jiajia Li, et al.
Published: (2019) -
Patient preferences for active ulcerative colitis treatments and fecal microbiota transplantation
by: Deborah A. Marshall, et al.
Published: (2024) -
The value of noninvasive scoring systems for the diagnosis of advanced fibrosis in Egyptian patients with nonalcoholic fatty liver disease
by: Rokaya A Mohamed, et al.
Published: (2014) -
The role of serum S100A12 (calgranulin C) as a diagnostic marker in Egyptian patients with irritable bowel syndrome and ulcerative colitis
by: Yousry Hashem, et al.
Published: (2018) -
Utility of fecal calprotectin as a discriminative biomarker between ulcerative colitis and irritable bowel syndrome and its ability to be used for the assessment of the remission stage of ulcerative colitis
by: Hossam M Elsaadany, et al.
Published: (2016)